G. Poda

发表

Calculation of molecular lipophilicity: state of the art and comparison of methods on more than 96000 compounds

R. Mannhold, G. Poda, Claude Ostermann, 2009, Journal of pharmaceutical sciences.

Can we estimate the accuracy of ADME-Tox predictions?

H. Mewes, G. Poda, I. Tetko, 2006, Drug discovery today.

Benzothiophene inhibitors of MK2. Part 1: structure-activity relationships, assessments of selectivity and cellular potency.

David R. Anderson, G. Poda, R. Kurumbail, 2009, Bioorganic & medicinal chemistry letters.

Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds.

G. Poda, I. Tetko, 2004, Journal of medicinal chemistry.

Reconstitution and characterization of eukaryotic N6-threonylcarbamoylation of tRNA using a minimal enzyme system

G. Poda, D. Durocher, A. Caudy, 2013, Nucleic acids research.

New Developments in Hydrogen Bonding Acidity and Basicity of Small Organic Molecules for the Prediction of Physical and ADMET Properties. Part 2. The Universal Solvation Equation

Nikolai S. Zefirov, Polina V. Oliferenko, Alexander A. Oliferenko, 2009, J. Chem. Inf. Model..

Structure and mechanism of action of the hydroxy aryl aldehyde class of IRE 1 endoribonuclease inhibitors

G. Poda, D. Durocher, F. Sicheri, 2015 .

Structure and mechanism of action of the hydroxy aryl aldehyde class of IRE1 endoribonuclease inhibitors

G. Poda, D. Durocher, F. Sicheri, 2014, Nature Communications.

Screening of chemical libraries in pursuit of kallikrein-5 specific inhibitors for the treatment of inflammatory dermatoses

G. Poda, E. Diamandis, I. Prassas, 2019, Clinical chemistry and laboratory medicine.

Structure-based design and synthesis of pyrazinones containing novel P1 'side pocket' moieties as inhibitors of TF/VIIa.

G. Poda, R. Kurumbail, W. Stallings, 2005, Bioorganic & medicinal chemistry letters.

Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).

David R. Anderson, Nicole Caspers, G. Poda, 2007, Journal of medicinal chemistry.

Benzothiophene inhibitors of MK2. Part 2: improvements in kinase selectivity and cell potency.

David R. Anderson, G. Poda, R. Kurumbail, 2009, Bioorganic & medicinal chemistry letters.

Unleashing the therapeutic potential of human kallikrein-related serine proteases

G. Poda, E. Diamandis, I. Prassas, 2015, Nature Reviews Drug Discovery.

Bending rigid molecular rods: formation of oligoproline macrocycles.

G. Poda, Vishal Rai, A. Yudin, 2012, Chemistry.

Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure-activity relationship.

G. Poda, R. Kurumbail, S. Selness, 2011, Bioorganic & medicinal chemistry.

Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction.

G. Poda, C. Arrowsmith, M. Schapira, 2013, ACS medicinal chemistry letters.

Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5

G. Poda, C. Arrowsmith, M. Schapira, 2012, The Biochemical journal.

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

G. Poda, G. Superti-Furga, K. Bennett, 2015, Nature chemical biology.

Unleashing the therapeutic potential of human kallikrein-related serine proteases

G. Poda, E. Diamandis, I. Prassas, 2015, Nature Reviews Drug Discovery.

Structure-Activity Relationships for Interaction with Multidrug Resistance Protein 2 (ABCC2/MRP2): The Role of Torsion Angle for a Series of Biphenyl-Substituted Heterocycles

G. Poda, Y. Lai, L. Xing, 2007, Drug Metabolism and Disposition.

An allosteric inhibitor of protein arginine methyltransferase 3.

Jian Jin, Matthieu Schapira, Alena Siarheyeva, 2012, Structure.

Promising Aedes aegypti Repellent Chemotypes Identified through Integrated QSAR, Virtual Screening, Synthesis, and Bioassay

Polina V. Oliferenko, Natasha M. Agramonte, G. Poda, 2013, PloS one.

Correction: Promising Aedes aegypti Repellent Chemotypes Identified through Integrated QSAR, Virtual Screening, Synthesis, and Bioassay

Polina V. Oliferenko, Natasha M. Agramonte, G. Poda, 2014, PLoS ONE.

ToxAlerts: A Web Server of Structural Alerts for Toxic Chemicals and Compounds with Potential Adverse Reactions

Igor V. Tetko, Iurii Sushko, Vladimir Potemkin, 2012, J. Chem. Inf. Model..

Prediction of Log P with Property‐Based Methods

Igor V. Tetko, Gennadiy I. Poda, G. Poda, 2007 .

Accurate In Silico log P Predictions: One Can't Embrace the Unembraceable

Igor V. Tetko, Raimund Mannhold, Claude Ostermann, 2009 .

Large‐Scale Evaluation of log P Predictors: Local Corrections May Compensate Insufficient Accuracy and Need of Experimentally Testing Every Other Compound

Raimund Mannhold, Claude Ostermann, R. Mannhold, 2009, Chemistry & biodiversity.

Expression, purification and functional characterization of IkappaB kinase-2 (IKK-2) mutants.

G. Poda, R. Kurumbail, G. Mbalaviele, 2010, Protein expression and purification.

Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode.

David R. Anderson, G. Poda, Betsy S. Pierce, 2010, Bioorganic & medicinal chemistry letters.

Strategy to Target the Substrate Binding site of SET Domain Protein Methyltransferases

Matthieu Schapira, Fengling Li, Masoud Vedadi, 2013, J. Chem. Inf. Model..

Reconstitution and characterization of eukaryotic N6-threonylcarbamoylation of tRNA using a minimal enzyme system

G. Poda, D. Durocher, A. Caudy, 2013, Nucleic acids research.